Last reviewed · How we verify
NCT03902964: EACE
Needs Assessment After Cancer in Patients Treated for Breast Cancer
trial in Breast Neoplasm Female in 139 participants. Completed in 1 February 2019.
1 February 2019
Quick facts
| Lead sponsor | Institut Jean-Godinot |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 139 |
| Start date | 1 December 2018 |
| Primary completion | 1 February 2019 |
| Estimated completion | 1 February 2019 |
| Sites | 1 location across France |
Conditions studied
- Breast Neoplasm Female — all drugs for Breast Neoplasm Female →
- Quality of Life — all drugs for Quality of Life →
- Fear Cancer — all drugs for Fear Cancer →
Sponsor
Institut Jean-Godinot — full company profile →
Who can join
Adults 18 to 80, female only, with Breast Neoplasm Female or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
observational monocentric study
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03902964
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Neoplasm Female
Currently open trials in the same condition.
- NCT07465523 — A Novel Approach in the Evaluation of Breast Masses With Doppler US · recruiting
- NCT06711523 — Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy · Phase 3 · active not recruiting
- NCT05277935 — Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib · NA · recruiting
- NCT06234137 — A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrot · NA · recruiting
- NCT04812652 — Digitally Distributed Yoga for Women Treated for Breast Cancer · NA · active not recruiting
Other Institut Jean-Godinot trials
Trials by the same sponsor.
- NCT07458204 — Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast · Phase 2 · not yet recruiting
- NCT07242261 — Non-invasive Characterisation of Oral Carcinomas in Patients With Fanconi Anaemia · NA · not yet recruiting
- NCT06356363 — Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway (Onco-PREMs) · not yet recruiting
- NCT05641012 — Association Between Helioderma and Response to Immunotherapy in Patients With Metastatic Melanoma · unknown
- NCT04108221 — Study Comparing Two Methods of TransversusAbdominis Plane · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03902964 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut Jean-Godinot
- Last refreshed: 4 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03902964.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing